Jim Wassil - Mar 15, 2024 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
CHIEF OPERATING OFFICER
Signature
/s/ Ron A. Metzger, Attorney-in-Fact
Stock symbol
PCVX
Transactions as of
Mar 15, 2024
Transactions value $
-$103,435
Form type
4
Date filed
3/19/2024, 04:26 PM
Previous filing
Mar 4, 2024
Next filing
Apr 3, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Award $0 +4.1K +1.87% $0.00 223K Mar 15, 2024 Direct F1
transaction PCVX Common Stock Tax liability -$103K -1.48K -0.67% $69.70 221K Mar 15, 2024 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of Common Stock underlying restricted stock units ("RSUs") issued in lieu of a cash bonus by election of the Reporting Person, such election available to all of Issuer's senior management. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The RSUs are fully vested upon the date of grant.
F2 Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of RSUs.